2029 Compliance FDA Medicaid 
Innovaare Compliance
MARCH 1, 2022
1] The Centers for Medicare & Medicaid Services (CMS) has to establish an annual Part B premium that will adequately fund projected Medicare spending and maintain an adequate reserve in case actual costs are higher than estimated. annually on average between 2021 and 2029 compared to 4.4% in 2021 to $170.00
Hall Render
MARCH 3, 2023
NATIONAL 14 rural senators push CMS to extend low-wage hospitals’ payment bump in FY2024 American Hospital Association voices support for telehealth expansion bill Behavioral health market to hit $262B by 2029 Biden administration moves to establish ‘guardrails’ for telehealth prescriptions CMS Officials Confirm End of PHE Nursing (..)
Healthcare Law Blog
AUGUST 25, 2022
Drugs eligible for negotiation must be FDA-approved for at least 7 years and marketed in conformance with the Federal Food, Drug, and Cosmetic Act. Program Compliance. Drug manufacturers may also be assessed an excise tax between 65%-95% depending upon the number of days that the drug manufacturer is out of compliance.
Expert insights. Personalized for you.
52 
Let's personalize your content